Advanced Prostate Cancer Clinical Trials
2 recruiting trials for Advanced Prostate Cancer. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Advanced Prostate Cancer clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Maastricht Radiation Oncology (1), Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is HDR brachytherapy (procedure, 1 trial), followed by Diagnostic biopsy, Whole Body-Magnetic Resonance Imaging (WB-MRI).
Track Advanced Prostate Cancer trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Lab Research Using Mini-tumors to Study Prostate Cancer Treatments
For men with an aggressive form of prostate cancer, finding the right and effective treatment right away is challenging. Many of these men face a high risk of cancer recurrence:...
Whole Body MRI in Oncology
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Advanced Prostate Cancer, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Advanced Prostate Cancer, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Advanced Prostate Cancer, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.